Video Experimental Relacionado

Updated: Jul 21, 2026

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

Una frecuente mutación del gen LRRK2 asociada con la enfermedad de Parkinson autosómica dominante

Alessio Di Fonzo¹, Christan F Rohé, Joaquim Ferreira

¹Department of Clinical Genetics, Erasmus MC Rotterdam, PO Box 1738, 3000 DR Rotterdam, Netherlands.

Lancet (London, England)

|February 1, 2005

Resumen

Una mutación común en el gen de la Leucina-Rich Repeat Kinase 2 (LRRK2), Gly2019Ser, está relacionada con la enfermedad de Parkinson autosómica dominante. Este hallazgo confirma el papel de LRRK2 en la neurodegeneración en diversas poblaciones.

Área de la Ciencia:

La neurogenética es la neurogenética.
Biología Molecular Biología Molecular
Neurología Neurología.

Sus antecedentes:

Las mutaciones en el gen LRRK2 (Leucine-Rich Repeat Kinase 2) están asociadas con formas autosómicas dominantes de la enfermedad de Parkinson.
La identificación de mutaciones específicas y su prevalencia es crucial para comprender los mecanismos de la enfermedad y los patrones de herencia.

Objetivo del estudio:

Investigar la frecuencia y distribución de las mutaciones del gen LRRK2 en familias con enfermedad de Parkinson autosómica dominante.
Para caracterizar el fenotipo clínico asociado con las mutaciones LRRK2 identificadas.

Principales métodos:

Se extrajo ADN genómico de pacientes pertenecientes a 61 familias no relacionadas con la enfermedad de Parkinson y la herencia autosómica dominante.
La región codificante del gen LRRK2 se amplificó utilizando la reacción en cadena de la polimerasa (PCR).
Los productos de PCR fueron secuenciados para identificar mutaciones.

Principales resultados:

Se identificó una mutación heterocigótica, Glicina a Serina en la posición 2019 (Gly2019Ser), en el gen LRRK2.
Esta mutación Gly2019Ser se encontró en 4 de las 61 (6,6%) familias.
Las familias afectadas eran de diversos orígenes étnicos (Italia, Portugal, Brasil).
La presentación clínica asociada con la mutación fue variable, incluyendo el inicio temprano y tardío de la enfermedad de Parkinson.

Conclusiones:

El estudio confirma una asociación significativa entre las mutaciones del gen LRRK2 y la enfermedad de Parkinson autosómica dominante.
La mutación Gly2019Ser representa una causa genética común de la enfermedad de Parkinson dominante hereditaria en diferentes poblaciones.
Las mutaciones de LRRK2 contribuyen a la neurodegeneración en la enfermedad de Parkinson, con un amplio espectro fenotípico.

Más Videos Relacionados

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Videos de Conceptos Relacionados

Genetic Lingo

Genetic Lingo

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...